MRMD stock has been an investor favorite since 2018. MariMed (OTCQB:MRMD) built its name by providing consulting services to the US cannabis industry—operating in the ancillary sector has proven very lucrative for many. Now, however, it is buying its own customers outright.
At the time of writing, these shares are down almost 4%, selling for $3.36 on the OTCQB. Should you keep an eye on MRMD stock? Let’s check it out.
MRMD StockMariMed grew its business exponentially in 2018. It began simple, providing consulting and advisory services to the US cannabis industry. Its ...
Read The Full Article On PotStockNews.com
Get the latest marijuana stock news, cannabis on stock news on PotStockNews
All content provided by Pot Stock News is subject to our Terms Of Use and Disclaimer.